Amgen

Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tue, 03/13/12 - 11:07 am
painkillers
NGF blockers
Amgen
Regeneron
JNJ
5 Biotech Stocks Undervalued By EPS Trends
Seeking Alpha
Sun, 03/11/12 - 11:56 am
Anika
Amgen
Illumina
Questcor Pharmaceuticals
ViroPharma
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Fri, 03/9/12 - 10:49 am
FDA
advisory panels
Xgeva
Amgen
Vivus
Qnexa
Consumer group sues 8 drugmakers over drug coupons
Yahoo/AP
Wed, 03/7/12 - 03:25 pm
drug coupons
lawsuits
Pfizer
Abbott Laboratories
Amgen
AstraZeneca
GSK
Bristol-Myers Squibb
Novartis
Merck
Threshold Scores Big With Pancreatic Cancer Data
Seeking Alpha
Mon, 03/5/12 - 11:08 am
pancreatic cancer
Threshold Pharmaceuticals
TH-302
Amgen
Array Biopharma
Micromet
Merck
Pharmacyclics
Roger Perlmutter’s Parting Thoughts on Amgen
Xconomy
Fri, 03/2/12 - 10:19 am
Amgen
R&D
Roger Perlmutter
Judge refuses to halt Amgen-Micromet deal
Yahoo/AP
Thu, 03/1/12 - 06:03 pm
Amgen
Micromet
M&A
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Wed, 02/29/12 - 04:52 pm
Merck
Pfizer
Bristol-Myers Squibb
Chelsea Therapeutics
Affymax
Astex
JNJ
Discovery Labs
Ariad Pharmaceuticals
NeurogesX
Amgen
Not Just Any Biotech Stock Will Do
Motley Fool
Sat, 02/25/12 - 09:20 am
PDL Biopharma
Amgen
Threshold Pharmaceuticals
5 Innovative Healthcare Companies With Histories Of Strong Growth
Seeking Alpha
Fri, 02/17/12 - 09:00 am
Abbott Laboratories
Novartis
JNJ
Allergan
Amgen
FTC ends review of Amgen's purchase of Micromet
Yahoo/AP
Thu, 02/16/12 - 09:31 am
Amgen
Micromet
FTC
M&A
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
Seeking Alpha
Tue, 02/14/12 - 11:19 am
Alexion
Gilead
Amgen
Soliris
Biogen Idec
Amgen To Near $100, Outperforming Pfizer
Seeking Alpha
Sun, 02/12/12 - 11:23 am
Pfizer
Amgen
Which Pharma Spent The Most R&D On Each Drug?
Pharmalot
Fri, 02/10/12 - 10:54 am
R&D
Amgen
AstraZeneca
Abbott Laboratories
Eli Lilly
Medgenics' Disruptive Biotechnology Is One To Watch
Seeking Alpha
Wed, 02/8/12 - 03:13 pm
Medgenics
Amgen
Prolor
Bristol-Myers Squibb
Protalix BioTherapeutics
FDA panel votes against Xgeva for prostate cancer
Yahoo/AP
Wed, 02/8/12 - 03:12 pm
prostate cancer
Xgeva
FDA
Amgen
Can Amgen Convince Docs to Recommend Xgeva Approval?
Motley Fool
Wed, 02/8/12 - 09:32 am
Amgen
Xgeva
physicians
prostate cancer
FDA
FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
Yahoo/AP
Mon, 02/6/12 - 09:47 am
FDA
Amgen
prostate cancer
Xgeva
Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Yahoo/Fly on the Wall
Fri, 02/3/12 - 10:00 am
Xgeva
Amgen
prostate cancer
advisory panels
Which Big Biotech Is the Best Bet?
Motley Fool
Tue, 01/31/12 - 08:01 am
Gilead
Amgen
Celgene
Biogen Idec

Pages